RE:RE:RE:RE:RE:RE:1 million+ in volume today? Thanks for sharing your thoughts Starkicker. So I guess what this stock really needs then is a P.R. showing investors at least one big pharma customer and how much that is worth in terms of sales revenue to get things started to start building more investor confidence. Even just one big pharma customer, one should want to see other big customers buying from LABS also so that LABS does not have all of it's revenue eggs in a single basket. But to be fair to LABS, just one big pharma customer is a little safer because at the moment LABS is the only FDA approved cannabinoid supplier.
I'll admit, I have a bit more tolerance for risk, if the facts line up but even that is no gurantee at all. U.S. Government (Pentagon's Dept of Naval Research) burned me when they exercised their right of access to the base patents and never allowed the technology to be commercialized on a large scale, especially within new types of computer processors and computer memory....that technology sits inside of fighter jets now that boot up all flight and weapons systems instantly...and I mean boot up instantly like as in turning on a light switch.
Good strategy, 5% max on start up young companies.